John Quelch Marketing KnowHow RSS Feed

How To Create A Blockbuster

7:06 PM Monday September 1, 2008

Tags:Branding, Marketing, Sales

The importance of blockbusters has been challenged recently by Chris Anderson's long tail theory that you can make money in many creative industries by selling specialized products to niche markets identified via the internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to "finding a needle in a haystack when you need it." He also worries that a company is at risk if sales depend too much on one or two megabrands that could run into lawsuits from generic competitors or regulatory challenges.

On the other hand, the president of Warner Brothers (think Batman etc) aims "to take advantage of what has become a very global market by focusing on bigger films that require a bigger commitment." He believes in blockbusters and his strategy is to create more of them.

The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable. Drug research initiatives often dead end but occasionally lead in an unexpected direction to a blockbuster result. Some big budget movies are flops, others are sleepers, others meet expectations.

Perhaps the CEO of GSK is really telling us that he sees no promising blockbusters in the drug pipeline. In a globally integrated market, blockbuster brands that address common consumer needs are more important than ever. Consumers around the world are excited to share common experiences. Blockbusters also motivate salespeople, get them access to customers and drive distribution for other products in a company's portfolio. A company's commitment to searching out potential blockbusters and then investing in marketing to convert potential to reality attracts and retains top scientists and creatives.

Of course, any company needs a portfolio of development projects, some with predictable sales results, others more risky. The former pay for the company's daily bread and butter and fund R&D on future blockbusters. Inverness Medical Innovations, for example, is doing exactly that, milking its number one worldwide position in pregnancy test kits to fund frontier research into cardio diagnostics.

More risky than pursuing blockbusters is not to pursue them, to condemn your enterprise to a lifetime of slave labor harvesting the long tail of micro-opportunities rather than imagining, pursuing and marketing the global solution to an important, widely shared problem.

What then makes a blockbuster? Here are the Five S's, the five defining characteristics of blockbusters. How does your brand stack up?

  1. Sheer size. A blockbuster has a transformational impact on a company and an industry, often opening up new markets worldwide. Blockbusters break sales records and exceed expectations. Around 100 pharmaceutical brands exceed $1 billion in annual sales. Procter & Gamble has 23 such brands.
  2. Speed. It's not just the sales volume, it's the speed of the sales trajectory. Remember that the original blockbuster was a bomb that could destroy an entire city block. Blockbuster brands address pressing consumer needs so well that they often enjoy vertical sales lift-off. Think Viagra.
  3. Scarcity. A blockbuster brand is often in such high demand that stock-outs and shortages occur in the market. Remember the consumer lines to buy the new i-Phone As imitation is the sincerest form of flattery, the speedy availability of counterfeits is another indicator of popularity.
  4. Sustainability. A blockbuster brand is not a one hit wonder. It is a gift that keeps on giving. Remember Intel's Pentium chip. Or look at the seven Harry Potter books and the five companion movies. Adding DVD and merchandise sales, and theme parks etc., Advertising Age valued the Potter economy at $15 billion.
  5. Sizzle. A blockbuster does not just address an important need. It does so in an exciting and accessible way. Pfizer's Lipitor was not the first cholesterol reducer but superior marketing and sales made Lipitor number one. And, in the movie world, remember the magical and memorable special effects in the Star Wars series.

Are there additional criteria that define a blockbuster in your mind?

People who read this also read:

 
* * *
Sign up for the Weekly Hotlist, a weekly email roundup featuring the top posts from HarvardBusiness.org and HBR.org.

Never miss a new post from your favorite blogger again with the HarvardBusiness.org Daily Alert email. The Alert delivers the latest blog posts from HarvardBusiness.org and HBR.org directly to your inbox every morning at 8:00 AM ET.


Trackbacks

TrackBack URL for this entry:
http://blogs.harvardbusiness.org/cgi-bin/mt/mt-tb.cgi/2745

Listed below are links to weblogs that reference How To Create A Blockbuster:

Blockbusters Dead or Alive from Circle of Health Blog:
There is a pretty interesting article over on the Harvard Business Review blog by John Quelch, one of the world’s marketing experts.  He draws an interesting comparison of the debate over the roles that blockbuster products will play going forwa... More

Tracked on September 2, 2008 22:59

Comments

Great article. The unfortunate reality for pharmaceutical blockbusters is that the Sustainability and Scarcity dimensions do not last. DC Comics owns Batman and Warner Brothers owns the film. In 10 years from now, the character’s value will likely be consistent (over 50 years for Batman), and the film will still be a sellable asset (though dated with a smaller market). Blockbuster drugs enjoy a few years of on-market patent protection at best before generics completely cannibalize the market (not just reduce, as you would expect any product over time) – importantly here, without regard to brand equity and/or loyalty that blockbusters often engender in consumers.

The other limiting factor for drug companies is the Sheer size dimension. With some form of medical treatment already available for many conditions afflicting large populations, firms are competing in building a better iPod until our science evolves where we invent more cures instead of treatments.

So the question I am left with in reviewing the 5 S’s is the relationship between blockbuster and the market: are blockbusters truly blockbusters because they redefine markets? If so, another important S might be Set – they set new standards by which competitors will need to compete.

Jason Burke
http://www.sas.com

- Posted by Jason Burke 
September 2, 2008 5:08 PM

I'm guilty but this article has lost all credibility with me with this statement alone:
A blockbuster does not just address an important need. It does so in an exciting and accessible way. Pfizer's Lipitor was not the first cholesterol reducer and was no better than Merck's Zocor, but superior marketing and sales made Lipitor number one. And, in the movie world, remember the magical and memorable special effects in the Star Wars series.

Lipitor was far and away more effective than Zocor in reducing cholesterol. Every study has confirmed this and specifically that it limited mortality events at much hire rates.

By including that statement I've got to include that you've over simplified many elements just to have "sizzle" to the point where its no longer relevant.

- Posted by Mikal 
September 2, 2008 7:48 PM

Sense.

Does it make sense?

Common sense and dollars and sense.

Since you asked how how our brand stacks up, we offer our brand for stackability.

It's an instant mobile global marketing site www.GripOffs.mobi where advertisers can post their own eCoupon offers with barcodes, change them at will, and monitor the real-time results over their areas of exposure from local to global. It can be changed in an instant by them.

Users (all of us), using our mobile phone, go to the site for all of the available deals being offered in whatever area we're in - one-stop location for all advertisers to be for when we're making a decision, say, of where to go to lunch right now.

Restaurants could have different breakfast, lunch and dinner specials everyday.

Instant Mobile Global Marketing.


- Posted by Jim Dugan 
September 4, 2008 11:37 AM

Thanks for highlighting the relative performance of Lipitor over Zocor. You are correct that the drugs are not equivalent in their effects and I have amended the blog post accordingly by removing the Zocor reference. Thanks again

- Posted by John Quelch 
September 4, 2008 3:27 PM

Blockbusters can be relative in size, too. At a local level the same five characteristics can play out to great effect. You can make a big splash in a small pond.

- Posted by Martin Jelsema 
September 4, 2008 8:08 PM

I have aa file going on Market Research to help me evaluate Private Placements most of which DO NOT have their target market
well identified.

Pleasem refer me to publications which will help me recognize the many types of market research such mas shott gunning vs one on one interviews. Your help appreciated - much.

- Posted by Duane Byron Carlson 
September 8, 2008 1:21 AM

I question the need for Scarcity in the creation of a blockbuster. You may need the scarcity at initial launch of a consumer electronics devices like the iPhone, however to maintain a brand over the years as a block buster takes a lot more than scarcity, it really demands the creation of a portfolio that can deliver to the target audience. Creating a blockbuster implies that all the users of a specific good gravitate to YOUR blockbuster over others regardless of the 4 P's (Price, Place, ,,,) , implying that you need to keep the brand fresh, and the value proposition attractive.

Everyone gravitates to a Latte from Starbucks, there is no scarcity today. The real issue at hand is how to keep the blockbuster going for decades! Think Pampers.

- Posted by yojak 
September 10, 2008 8:49 PM

As I read your blog post I couldn't help thinking about Clayton Christenson's innovation market model. It would appear that the blockbuster phenomenon is similar to his "fault line" category where market leaders fail to meet the needs of the changing marketplace. The long tail theory fits well into Christenson's model also in that the successes Anderson describes can be found in innovations around customer experience or customer-touching processes or business model.

All of the examples used in the blog post were products. The concept of a blockbuster from a services industry perspective is challenging. Is it more difficult to find a "blockbuster" in this industry? Sometimes I think so and anecdotal experience would suggest the same, especially if the movie entertainment industry is the comparison. If you compare the services and pharma industries, then perhaps the level of challenge is more equal.

Do you have any examples of blockbusters from a services delivery perspective?

- Posted by Faun deHenry 
September 11, 2008 9:52 AM

Good article. Just as important to defining a blockbuster is defining the competencies that allow a firm not only to manage the life cycle of a blockbuster, but create the next. I think the challenge with our capital structure is the overwhelming pressure to manage the short term (obvious I know) which leads to the milking of the "one" as opposed to cultivating and truly investing in organization and inputs that lead to future blockbusters. Compounding this external pressure is the internal culture/human element which often shifts from a focus on building the company to managing one's career; especially when faced with the difficulty of creating the next winner. Defining the tools, practices and capabilities to create an organization that can manage the first and creation of the next blockbuster would be of incredible value to leadership.

- Posted by Michael Voevodsky 
September 15, 2008 10:58 AM

As good as it sounds, the fundamental premise rests on leadership in innovation and product development. That does not umbrella for all the industries categorically, market capitalisation has oftenly thrived in free market economies. Over the last two decades, an increasing number of industries have evolved from vertical integration to more horizontal structures where firms design and manufacture components that are later assembled by third parties for the final customer. In these horizontal industries, firms may be "complementors," rather than customers, suppliers, or competitors. Classic examples of complementors include Intel and Microsoft. Similar complementor relationships arise in industries such as communications, consumer electronics, automobiles, and health care.

- Posted by Henry Maigurira 
September 15, 2008 12:35 PM

Interesting point of view!

The problem with blockbuster-based business models is that they are incredibly vulnerable. Why has the music/record industry suffered from illegal downloading. Because they were so dependent on a small base of super-star artists and their blockbuster hits.

Pharma is very similar. The day the patent of a blockbuster drug expires you will find generics on the market.

Building a business model based "on the long tail theory" is less risky because you do not depend on a small base of products. Yet, the task of building such a platform is equally challenging...

- Posted by Alex Osterwalder 
September 17, 2008 8:07 AM

Scarcity can actually KILL a blockbuster. In my days working on billion dollar brands at P&G, I saw occasions where a product was selling "too fast." If you cannot make enough product to satisfy demand, retailers end up cutting their support (that end-cap goes to something else) then are slow to re-up one you catch up to demand. As a result, a hot product can quickly lose momentum and fail to become a blockbuster...

- Posted by Bob Gilbreath 
September 19, 2008 8:52 AM

Brings to mind the old line: “Good companies will meet needs; great companies will create markets.” However, it is the Survivor Bias that allows us to believe that one can create markets and blockbusters deliberately (just as we celebrate the Infinite Monkey's recreation of Shakespeare's works because, like beating the market, we want to believe it can be done). Since HBS has no blockbuster, does this mean that JQ and his colleagues are condemned "to a lifetime of slave labor harvesting the long tail of micro-opportunities"?

- Posted by Bud Morten 
September 22, 2008 4:59 PM

Join The Discussion

* Required Fields




Verification (needed to reduce spam):

Posting Guidelines

We hope the conversations that take place on HarvardBusiness.org will be energetic, constructive, free-wheeling, and provocative. To make sure we all stay on-topic, all posts will be reviewed by our editors and may be edited for clarity, length, and relevance.

We ask that you adhere to the following guidelines.

  1. No selling of products or services. Let's keep this an ad-free zone.
  2. No ad hominem attacks. These are conversations in which we debate ideas. Criticize ideas, not the people behind them.
  3. No multimedia. If you want us to know about outside sources, please point to them, Don't paste them in.
We look forward to including your voices on the site - and learning from you in the process.

The editors

John Quelch

John Quelch was one of ten marketing experts profiled in the 2007 book, Conversations with Marketing Masters, authored by Laura Mazur and Louella Miles. A professor at Harvard Business School since 1979, he is known worldwide for his research on global marketing, global branding and marketing communications.

John is a non-executive director of WPP Group plc, the world’s second largest marketing services company, and of Pepsi Bottling Group. He served previously as a director of Reebok International.

Available Now

Greater Good book cover image
Greater Good: How Good Marketing Makes for Better Democracy (Hardcover)
By John A. Quelch and
Katherine Jocz

Learn how business innovators like Amazon's Jeff Bezos and Pixar's Ed Catmull achieve breakthrough results.
Harvard Business Review

ADVERTISEMENT

Browse Our Store

Productive Business Dialogue (Simulation)

This simulation will help you learn how to craft conversations that are fact based, minimize defensiveness, and draw out the best thinking from everyone involved.

Measuring Marketing Performance

In many organizations, marketing exists far from the executive suite and the boardroom. Learn how to improve the link between high level corporate strategy and the marketing function.

Management Tip of the Day Enrollment
SPONSORED BY:  

ADVERTISEMENT

Free Downloads